On April 30, 2022, Songzi City People's Government Mayor Wang Wei, Deputy Mayor Li Wei, Secretary of China Merchants Bureau Qin Zhangyan, Director of the city Office in Han Xu Tao, Secretary of the Town Committee of Eight Bao Town Zou Feng and others visited Ruichen Kangda Bio-Medicine (Wuhan) Co., LTD. (hereinafter referred to as Ruichen Kangda) Optics Valley Bio-City R&D Center to investigate and guide the work. Mayor Wang Wei and his delegation visited the R & D center of Ruichen Kangda, and asked in detail the precautions in the test process and the use of various instruments and methods.

　　During the inspection, Mayor Wang Wei carefully listened to Ruichen Kangda's development history, company philosophy, core team and past project experience, as well as the existing mature project market share and production technology advantages, and asked about the future project plan to put into production. Mayor Wang Wei pointed out that the products developed by Ruichen Kangda are cutting-edge materials and high-level products. Ruichen Kangda has a high-quality team and pays attention to the research and development of high-tech technology. Ruichen Kangda is a company with original creativity, competitiveness and vigor. Most of the founding team of the company are Hubei people, but also the greater Jingzhou area people, this visit is both a visit to the township enterprises, but also a door invitation, hope that the township enterprises for the development of their hometown to add confidence and momentum, to achieve a win-win situation.

　　Ruichen Kangda Biomedicine (Wuhan) Co., Ltd. was registered and established in August 2018 in East Lake High-tech Development Zone, Wuhan East Lake National Independent Innovation Demonstration Zone. The company has a high-quality and high-level R & D team led by a number of senior overseas returnees. The company focuses on technological research and innovation in the field of new materials and large health. Based on chemical synthesis, the company is committed to the development of new processes and new methods, the efficient construction of key drug intermediates and new material blocks, the development of characteristic apis and characteristic preparations based on new functional materials, to solve the problem of product accessibility from 0 to 1 and the problem of high-quality product acquisition from 1 to 100. The company firmly takes the end as the beginning, deeply understands customers, products, quality, and quality. The mission of empowering the pharmaceutical industry with chemistry is to empower the pharmaceutical industry and provide better medicines for patients. In 2020, the company has been recognized as a national high-tech enterprise and a technology "little giant" enterprise in Wuhan. 2021 National science and technology smes identified and "3551" Optics Valley high-level talent listed enterprises. In 2022, the School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, will obtain the qualification of professional master's joint training base.
　　The company has a complete set of kg laboratories and matching 100kg factories, as well as a sound R & D and quality management system, can well meet the needs of customers in different stages of process research and development. The company has established long-term business relations with more than 50 pharmaceutical companies such as Wuhan Renfu, Wuxi Apptec, Pharmaron, Nanjing Pharmaceutical Stone, Huahai Pharmaceutical, Zhejiang Tianyu, Hangzhou Lide, Guangzhou Fermizi, Suzhou Qinhao, Hangzhou Meisai, Suzhou Yulu, Wuhan Yuxiang, Shanghai Kesheng, etc. At the same time, the company has also established extensive technical cooperation with Wuhan University, Huazhong University of Science and Technology, Huazhong Agricultural University, Hubei University of Technology, Guangzhou Medical University and other universities.
　　Contact person: Liu Jun Tel: 13564855401 E-mail: liujun@rcchemtec.cnAddress: Room 502, Building 16, No. 388 Gaoxin 2 Road, Donghu New Technology Development Zone, Wuhan City